Tafluprost
Brand Formulations & Prices
1 brands sorted by unit price
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesTaflan SUD ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Instill one drop in the affected eye(s) once daily in the evening.
Use in children
: Use in pediatric patients is not recommended.
Use in elderly patients
: No overall differences in safety and effectiveness have been observed between elderly and other adult patients.
Tafluprost ophthalmic solution is contraindicated in patients who are hypersensitive to any component of this product.
The most frequently reported treatment-related side effect is ocular hyperemia. Rare side effects observed include eye irritation and blurred vision.
For ophthalmic use only.
To avoid possible contamination of the drops, do not touch the dropper tip or to any surface.
Should be used with caution in patients with active intraocular inflammation (e.g., iritis/uveitis).
If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes between applications.
Tafluprost, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce intraocular pressure by increasing uveoscleral outflow of aqueous humor.